Effectiveness of asthma preventer dispensing for preventing childhood asthma readmissions: a multisite cohort linkage study

ObjectivesTo (1) describe the dispensing of asthma preventers at hospital discharge and estimate its effect on hospital readmissions, and (2) estimate the effect of community asthma preventer dispensing on readmissions for the subgroup of children who were not prescribed an asthma preventer at discharge. DesignMultisite cohort study with linked administrative data. ParticipantsChildren aged 3-18 years admitted with asthma to a tertiary paediatric, mixed paediatric and adult, or regional hospital between 2017 and 2018. Main outcome measureHospital readmission for asthma within 12 months. ResultsOf the 767 participants, 201 (26.2%) were newly prescribed or requested to continue with asthma preventers. Of these, only 91 (45.3%) dispensed their discharge prescription within 3 days or had an active prescription. There was no evidence for a protective effect of discharge asthma preventer dispensing on asthma hospital readmissions within 12 months (OR 1.17, 95% CI 0.69 to 1.97, p=0.57). Of the 566 children who were not prescribed asthma preventers at discharge, 269 (47.5%) had one or more prescriptions dispensed in the community within 12 months. Participants who were in the protected period (asthma preventer dispensed) had reduced risk of an asthma hospital readmission (HR 0.61, 95% CI 0.36 to 1.02, p=0.06), including preschool children (HR 0.48, 95% CI 0.25, 0.93, p=0.03) on subgroup analysis. ConclusionsThere was a low rate for prescribing and dispensing of hospital discharge asthma preventers and no protective effect was found for its impact on readmissions. A protective effect on readmissions was found for community asthma preventer dispensing.

Automated summary

This study aimed to describe the dispensing of asthma preventers at hospital discharge and estimate its effect on hospital readmissions. The results showed a low rate of prescribing and dispensing of hospital discharge asthma preventers, and no protective effect was found for its impact on readmissions. However, community asthma preventer dispensing was found to have a protective effect on readmissions.